288 related articles for article (PubMed ID: 31478094)
1. Association Between Antipsychotic Medication Use and Diabetes.
Holt RIG
Curr Diab Rep; 2019 Sep; 19(10):96. PubMed ID: 31478094
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics and glucose homeostasis.
Bergman RN; Ader M
J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics: new drugs, new challenges.
Mathews M; Muzina DJ
Cleve Clin J Med; 2007 Aug; 74(8):597-606. PubMed ID: 17708131
[TBL] [Abstract][Full Text] [Related]
4. Weighing in: emergent diabetes mellitus and second-generation antipsychotics.
Dufresne RL
Ann Pharmacother; 2007 Oct; 41(10):1725-7. PubMed ID: 17785611
[TBL] [Abstract][Full Text] [Related]
5. [Schizophrenia, diabetes mellitus and antipsychotics].
Gury C
Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics and diabetes mellitus.
Lichiardopol R
Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621
[TBL] [Abstract][Full Text] [Related]
7. Management of weight gain associated with antipsychotics.
Birt J
Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
[TBL] [Abstract][Full Text] [Related]
8. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
9. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotics result in more weight gain in antipsychotic naive patients than in patients after antipsychotic switch and weight gain is irrespective of psychiatric diagnosis: A meta-analysis.
Bak M; Drukker M; Cortenraad S; Vandenberk E; Guloksuz S
PLoS One; 2021; 16(2):e0244944. PubMed ID: 33596211
[TBL] [Abstract][Full Text] [Related]
11. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
[TBL] [Abstract][Full Text] [Related]
12. Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications.
Russell JM; Mackell JA
CNS Drugs; 2001; 15(7):537-51. PubMed ID: 11510624
[TBL] [Abstract][Full Text] [Related]
13. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents.
Bretler T; Weisberg H; Koren O; Neuman H
BMC Med; 2019 Jun; 17(1):112. PubMed ID: 31215494
[TBL] [Abstract][Full Text] [Related]
14. Effect of age, family history of diabetes, and antipsychotic drug treatment on risk of diabetes in people with psychosis: a population-based cross-sectional study.
Foley DL; Mackinnon A; Morgan VA; Watts GF; Castle DJ; Waterreus A; Galletly CA
Lancet Psychiatry; 2015 Dec; 2(12):1092-8. PubMed ID: 26477242
[TBL] [Abstract][Full Text] [Related]
15. [Antipsychotic prescription assessment in general practice: metabolic effects].
Gignoux-Froment F; de Montleau F; Saravane D; Verret C
Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610
[TBL] [Abstract][Full Text] [Related]
16. [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics].
Scheen AJ; De Hert M
Rev Med Liege; 2005; 60(5-6):455-60. PubMed ID: 16035311
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms in endocrinology: Antipsychotic medication and type 2 diabetes and impaired glucose regulation.
Whicher CA; Price HC; Holt RIG
Eur J Endocrinol; 2018 Jun; 178(6):R245-R258. PubMed ID: 29559497
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy to limit weight gain caused by antipsychotic use.
Malhi GS; Mitchell PB
Expert Opin Pharmacother; 2003 Oct; 4(10):1679-86. PubMed ID: 14521478
[TBL] [Abstract][Full Text] [Related]
19. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
20. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults.
Citrome L; Kalsekar I; Baker RA; Hebden T
Curr Med Res Opin; 2014 Aug; 30(8):1629-41. PubMed ID: 24666104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
